Eirwen Miller, MD

Eirwen M. Miller, MD, discusses novel biomarkers that she believes will be important for endometrial cancer in the future.

Adding immunotherapy to chemotherapy is the new standard-of-care treatment for advanced or recurrent endometrial cancer, according to Eirwen Miller, MD.